Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery — to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer — the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months).

MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

“The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3,” explains Prof. Vansteenkiste. “In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells.”

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

“Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer,” says Prof. Vansteenkiste. “Postoperative chemotherapy is able to improve cure rates, but is sometimes poorly tolerated by patients recovering from thoracic surgery. In addition, not all patients are fit to receive chemotherapy. This is why the signal from this phase II randomized study is important: the reduction in risk of postoperative cancer relapse is similar to the one obtained with postoperative chemotherapy, while the side-effects of this new strategy are minimal compared to chemotherapy.”

Most patients only experience mild reactions at the injection site and fever within 24 hours of the injection, he explained. “Therefore, it is suitable for long-term maintenance treatment and for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment.” A large Phase III trial of the therapy, named MAGRIT, is now underway.

source: http://www.esmo.org/

More Treatment & Detox Articles

Daily aspirin use may cut risk of common breast cancer

Taking aspirin daily may reduce a woman’s risk of developing a common type of breast cancer, say American researchers. The team, led by Gretchen Gierach, found that intake of aspirin was linked to a small reduction in oestrogen receptor-positive (ER+) breast cancers. The discovery is important as around 75 per cent of cancers are oestrogen….

Research Suggests That Cigarettes’ Power May Not Be In Nicotine Itself

There may be a very good reason why coffee and cigarettes often seem to go hand in hand. A Kansas State University psychology professor’s research suggests that nicotine’s power may be in how it enhances other experiences. For a smoker who enjoys drinking coffee, the nicotine may make a cup of joe even better. And….

12-Step Treatment Programs and the Spiritual Foundation for Recovery

When Alcoholic’s Anonymous first began in the early 1930s, more than 75% of all addicts who took part in the program actually made a full recovery from their addiction to alcohol. These numbers are actually very high when compared with many of today’s current treatment modalities. Alcoholics Anonymous was the first to coin the 12-step….

Concern over teenage alcohol abuse

A campaign group has called for more research into the way alcohol can affect teenagers’ health. Alcohol Concern said it was worried that a rise in teenage drinking would lead to more people suffering alcohol-related illnesses at younger ages. The organisation called for further study as it emerged that a 22-year-old man was dying in….

Alcohol on TV 'prompts drinking'

People are more likely to turn to alcohol while watching TV if they see drinking being portrayed in films or adverts, a study shows. The research, led by a team from Radboud University in the Netherlands, monitored the behaviour of 80 young people while they watched television. Researchers found those who saw lots of alcohol….